4-73483958-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001133.2(AFM):c.106C>A(p.Gln36Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000516 in 1,529,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001133.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFM | NM_001133.2 | c.106C>A | p.Gln36Lys | missense_variant | 2/15 | ENST00000226355.5 | NP_001124.1 | |
AFM | XM_017007842.3 | c.106C>A | p.Gln36Lys | missense_variant | 2/13 | XP_016863331.1 | ||
AFM | XM_017007843.3 | c.106C>A | p.Gln36Lys | missense_variant | 2/11 | XP_016863332.1 | ||
AFM | XM_017007844.3 | c.106C>A | p.Gln36Lys | missense_variant | 2/11 | XP_016863333.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFM | ENST00000226355.5 | c.106C>A | p.Gln36Lys | missense_variant | 2/15 | 1 | NM_001133.2 | ENSP00000226355.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151998Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000176 AC: 4AN: 227558Hom.: 0 AF XY: 0.0000243 AC XY: 3AN XY: 123458
GnomAD4 exome AF: 0.0000552 AC: 76AN: 1377946Hom.: 0 Cov.: 28 AF XY: 0.0000567 AC XY: 39AN XY: 687592
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151998Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.106C>A (p.Q36K) alteration is located in exon 2 (coding exon 2) of the AFM gene. This alteration results from a C to A substitution at nucleotide position 106, causing the glutamine (Q) at amino acid position 36 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at